Robert C. Faulkner

Insider Reports History

Entity
Individual
Location
C/O Redmile Group, One Letterman Drive, Building D, Suite D, San Francisco, California
Signature
/s/ Robert C. Faulkner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert C. Faulkner:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Augmedix, Inc. Director Common Stock 41,461 $49.3 K $1.19 Jun 14, 2024 Direct
Science 37 Holdings, Inc. Former Director Common Stock 0 $0 $5.75 Mar 12, 2024 Direct
Science 37 Holdings, Inc. Former Director Stock Options (Right to Buy) 0 Mar 12, 2024 Direct

Insider Reports Filed by Robert C. Faulkner

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AUGX Augmedix, Inc. Jun 14, 2024 1 0 4 Jun 18, 2024 Director
AUGX Augmedix, Inc. Mar 15, 2024 1 0 4 Mar 19, 2024 Director
SNCE Science 37 Holdings, Inc. Mar 12, 2024 2 -154,048 4 Mar 13, 2024 Former Director
MDVL MedAvail Holdings, Inc. Feb 2, 2024 0 0 4 Feb 6, 2024 Director
AUGX Augmedix, Inc. Dec 15, 2023 1 0 4 Dec 19, 2023 Director
AUGX Augmedix, Inc. Aug 31, 2023 1 10,000 4 Sep 5, 2023 Director
AUGX Augmedix, Inc. Jul 13, 2023 1 0 4 Jul 17, 2023 Director
SNCE Science 37 Holdings, Inc. May 11, 2023 1 125,000 4 May 15, 2023 Director
AUGX Augmedix, Inc. Apr 14, 2023 0 0 3 Apr 21, 2023 Director
SNCE Science 37 Holdings, Inc. May 23, 2022 1 124,998 4 May 25, 2022 Director
SNCE Science 37 Holdings, Inc. Oct 7, 2021 1 0 4 Oct 12, 2021 Director
SNCE Science 37 Holdings, Inc. Oct 6, 2021 0 0 3 Oct 8, 2021 Director